Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales
FDA Law Blog
DECEMBER 4, 2023
An extended release (“ER”) opioid in legitimate pain management generally accompanies an IR opioid, with patients taking the ER opioid on a set schedule and the IR opioid as needed. On October 10th, based on ability to pay, the U.S. 11, 2023 ( DOJ Press Release ). 21 U.S.C. § 829; 21 C.F.R. Holiday CVS, 77 Fed. at 62,341.
Let's personalize your content